News & Insights | Compliance & Legal, Biotech & Pharma

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Building compliance from the ground up: Tim Stow’s vision at Galderma

How AI can become a ‘thought partner’ to compliance programs

Compliance Insider Contributor Guidelines

Pharmaceutical industry faces multiple challenges from government programs and regulations

Partners in progress: How Novo Nordisk transformed compliance into strategy

Social media and pharma, a necessary presence riddled with risks

Bridging business and ethics: A pharmaceutical compliance leader’s perspective

A fine balance with health systems’ HCP interactions

Industry examples offer a blueprint for stronger compliance

Compliance and the critical role in business success

Legal and compliance insights from a PAP perspective

Emerging trends shaping pharmaceutical compliance in 2025

Social media, influencers and digital opinion leaders

Can AI improve pharma compliance?

Status of safe harbor in Anti-Kickback Statute to improve patient access

Compliance program complexities: Insights from Teva’s head of compliance

Introducing Compliance Insider

Risk tolerance in pharmaceutical compliance: Dealing with shades of gray

Embracing technology is key for compliance professionals

Emerging business models in specialty pharmaceuticals

Quick Links